Lead sponsor
RespireRx
1 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
1
Trials led
0
Ongoing
175
Total enrollment
8
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
1
Trials by status
Completed
1
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment.Age 55-85Ph 2Completed175